Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jan
12
2017
Grassley Continues To Press CMS on Medicaid Drug Rebate Classifications: What Will Be the Fallout? Mintz
Jan
12
2017
Final Rules Released Covering 340B Ceiling Prices and Manufacturer Penalties McDermott Will & Emery
Jan
12
2017
Campbell Soup and Others Support Petition to Allow the Term ‘Potassium Salt’ on Ingredient Labels Keller and Heckman LLP
Jan
12
2017
FDA Finalizes Tobacco Product Intended Use Rules, Under a Risk of Rescission by Congress Mintz
Jan
12
2017
Supreme Court Declines to Revisit Broad Personal Jurisdiction Over ANDA Filers Mintz
Jan
11
2017
Australia Trademark Dispute: An Apple a Day Doesn’t Keep Litigation at Bay K&L Gates
Jan
11
2017
DC Council Passes Amendments to Alcohol Beverage Code McDermott Will & Emery
Jan
11
2017
2016-2017 Technical Review of Australian Gene Technology Regulations 2001 K&L Gates
Jan
11
2017
Trade Secret Dispute Brewing In Minnesota Jones Walker LLP
Jan
11
2017
FDA Reports Uptick in Antibiotic Use in Food Animals Keller and Heckman LLP
Jan
11
2017
Beyond the Eleventh Hour: FDA Prepares to Finalize Intended Use Amendments Despite Midnight Rule Relief Act Mintz
Jan
11
2017
Florida Board of Medicine Hearing on Telemedicine and Medical Marijuana Foley & Lardner LLP
Jan
10
2017
Food and Beverage Manufacturers That Use Added Sugar Be On Alert Womble Bond Dickinson (US) LLP
Jan
10
2017
Alcohol and Tobacco Tax and Trade Bureau Changes Under Fall Edition of Unified Agenda McDermott Will & Emery
Jan
10
2017
FDA Targets Tobacco Products Claims Keller and Heckman LLP
Jan
10
2017
How Big Pharma Taps Outside Ingenuity Greenberg Traurig, LLP
Jan
10
2017
Health Resources and Services Administration Announces Final Rule on Civil Monetary Penalties for Drug Manufacturers that Overcharge 340B Covered Entities Foley & Lardner LLP
Jan
10
2017
FDA Issues Final Guidance on Postmarket Cybersecurity Morgan, Lewis & Bockius LLP
Jan
10
2017
New Federal and State Initiatives Seek to Combat Antimicrobial Resistance Epstein Becker & Green, P.C.
Jan
10
2017
Tax Underreporting, FDA Import Lawsuit, Project OPEN: State Attorneys General January 9 Update Squire Patton Boggs (US) LLP
Jan
9
2017
FDA Extends Comment Period for Information and Draft Guidance on Fiber on Nutrition Facts Label Keller and Heckman LLP
Jan
9
2017
FDA Releases Biosimilar Guidance for Industry Foley & Lardner LLP
Jan
8
2017
Agribusiness and Food Issues to Watch for 2017 Armstrong Teasdale
Jan
6
2017
Delhi High Court Strikes Down Section 24(5) of the Plant Varieties Act as Unconstitutional Michael Best & Friedrich LLP
Jan
6
2017
21st Century Cures: Food and Drug Administration (FDA) Drug Provisions McDermott Will & Emery
Jan
6
2017
USDA Unveils New Program to Assess Animal Welfare Standards Keller and Heckman LLP
Jan
5
2017
Dismissal of Movie Candy Slack-Fill Case Leaves Sour Aftertaste: New York Federal Court Rejects Labeling Disclosure Defense Keller and Heckman LLP
Jan
5
2017
White House Announces Release of Final Update to the Coordinated Framework for the Regulation of Biotechnology Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins